Upgrade to SI Premium - Free Trial

SPTX (SPTX)

18.17 +1.07 (6.26%)

Chart
Today 6M 1Y 5Y

Upcoming Events

- Earnings (9/2/26)

Latest Headlines

Stifel Reiterates Buy Rating on Seaport Therapeutics (SPTX) June 9, 2026 3:34 AM - StreetInsider Seaport Therapeutics reports positive phase 1 data for GlyphAgo anxiety drug June 9, 2026 2:00 AM - StreetInsider PureTech Founded Entity Seaport Therapeutics Reports Positive Multiple-Ascending Dose Data from Phase 1 Proof-of-Concept Trial of GlyphAgo™ in Healthy Volunteers June 9, 2026 2:00 AM - BizWire Form 10-Q Seaport Therapeutics, For: Mar 31 June 8, 2026 7:16 AM - SEC Filing Form 8-K Seaport Therapeutics, For: Jun 08 June 8, 2026 7:12 AM - SEC Filing Seaport Therapeutics Reports First Quarter 2026 Financial Results and Highlights Recent Corporate and Clinical Progress June 8, 2026 7:05 AM - BizWire Seaport Therapeutics reports positive phase 1 data for anxiety drug candidate June 8, 2026 7:00 AM - StreetInsider Seaport Therapeutics Reports Positive Multiple-Ascending Dose Data from Phase 1 Proof-of-Concept Trial of GlyphAgo™ in Healthy Volunteers June 8, 2026 7:00 AM - BizWire Seaport Therapeutics to Participate in Two Upcoming Investor Conferences June 1, 2026 7:00 AM - BizWire Leerink Starts Seaport Therapeutics (SPTX) at Outperform May 26, 2026 6:05 AM - StreetInsider Citi Starts Seaport Therapeutics (SPTX) at Buy May 26, 2026 5:14 AM - StreetInsider JPMorgan Starts Seaport Therapeutics (SPTX) at Overweight May 26, 2026 3:22 AM - StreetInsider Stifel Starts Seaport Therapeutics (SPTX) at Buy May 26, 2026 3:21 AM - StreetInsider Goldman Sachs Starts Seaport Therapeutics (SPTX) at Early-Stage Biotech May 26, 2026 12:54 AM - StreetInsider Form SCHEDULE 13D Seaport Therapeutics, Filed by: GENERAL ATLANTIC, L.P. May 11, 2026 7:54 PM - SEC Filing Form SCHEDULE 13G Seaport Therapeutics, Filed by: GOLDMAN SACHS GROUP INC May 11, 2026 3:19 PM - SEC Filing Form 3 Seaport Therapeutics, For: May 04 Filed by: GAP Coinvestments CDA, L.P. May 6, 2026 9:17 PM - SEC Filing Form 3 Seaport Therapeutics, For: May 04 Filed by: GENERAL ATLANTIC, L.P. May 6, 2026 9:15 PM - SEC Filing Form 4 Seaport Therapeutics, For: May 04 Filed by: PureTech Health plc May 6, 2026 7:38 PM - SEC Filing Form SCHEDULE 13D Seaport Therapeutics, Filed by: ARCH Venture Fund XII, L.P. May 6, 2026 4:27 PM - SEC Filing Form 4 Seaport Therapeutics, For: Apr 30 Filed by: Zohar Daphne May 4, 2026 6:18 PM - SEC Filing Form 4 Seaport Therapeutics, For: May 04 Filed by: HEALY JAMES May 4, 2026 6:14 PM - SEC Filing Form 4 Seaport Therapeutics, For: Apr 30 Filed by: White Lauren May 4, 2026 6:14 PM - SEC Filing Form 4 Seaport Therapeutics, For: Apr 30 Filed by: Wheadon David E. May 4, 2026 6:11 PM - SEC Filing Form 4 Seaport Therapeutics, For: Apr 30 Filed by: PETERSON SANDRA E May 4, 2026 6:10 PM - SEC Filing Form 4 Seaport Therapeutics, For: Apr 30 Filed by: Gladstein Lana May 4, 2026 6:09 PM - SEC Filing Form 4 Seaport Therapeutics, For: Apr 30 Filed by: Chen Michael Cunyuan May 4, 2026 6:08 PM - SEC Filing Form 4 Seaport Therapeutics, For: Apr 30 Filed by: Torres Denice May 4, 2026 6:07 PM - SEC Filing Form 4 Seaport Therapeutics, For: Apr 30 Filed by: PAUL STEVEN M May 4, 2026 6:06 PM - SEC Filing Form 4 Seaport Therapeutics, For: May 04 Filed by: ARCH Venture Partners XII, LLC May 4, 2026 6:03 PM - SEC Filing Form 4 Seaport Therapeutics, For: Apr 30 Filed by: HOMBACH ROBERT J. May 4, 2026 6:03 PM - SEC Filing Form 4 Seaport Therapeutics, For: Apr 30 Filed by: Loebel Antony May 4, 2026 6:02 PM - SEC Filing Form 4 Seaport Therapeutics, For: Apr 30 Filed by: Mates Sharon May 4, 2026 6:01 PM - SEC Filing Form 8-K Seaport Therapeutics, For: May 04 May 4, 2026 4:28 PM - SEC Filing Form S-8 Seaport Therapeutics, May 4, 2026 6:02 AM - SEC Filing Form 424B4 Seaport Therapeutics, May 1, 2026 5:32 PM - SEC Filing Form EFFECT Seaport Therapeutics, May 1, 2026 9:19 AM - SEC Filing Seaport Therapeutics prices upsized IPO at $18 per share April 30, 2026 9:55 PM - StreetInsider Seaport Therapeutics Announces Pricing of Upsized Initial Public Offering April 30, 2026 9:55 PM - BizWire Form 3 Seaport Therapeutics, For: Apr 30 Filed by: PureTech Health plc April 30, 2026 9:35 PM - SEC Filing Form 3 Seaport Therapeutics, For: Apr 30 Filed by: PETERSON SANDRA E April 30, 2026 8:19 PM - SEC Filing Form 3 Seaport Therapeutics, For: Apr 30 Filed by: Zohar Daphne April 30, 2026 8:18 PM - SEC Filing Form 3 Seaport Therapeutics, For: Apr 30 Filed by: Mates Sharon April 30, 2026 8:14 PM - SEC Filing Form 3 Seaport Therapeutics, For: Apr 30 Filed by: Torres Denice April 30, 2026 8:14 PM - SEC Filing Form 3 Seaport Therapeutics, For: Apr 30 Filed by: White Lauren April 30, 2026 8:14 PM - SEC Filing Form 3 Seaport Therapeutics, For: Apr 30 Filed by: Pitts Jason April 30, 2026 8:12 PM - SEC Filing Form 3 Seaport Therapeutics, For: Apr 30 Filed by: Wheadon David E. April 30, 2026 8:11 PM - SEC Filing Form 3 Seaport Therapeutics, For: Apr 30 Filed by: HEALY JAMES April 30, 2026 8:10 PM - SEC Filing Form 3 Seaport Therapeutics, For: Apr 30 Filed by: PAUL STEVEN M April 30, 2026 8:10 PM - SEC Filing Form 3 Seaport Therapeutics, For: Apr 30 Filed by: CRANDELL KEITH April 30, 2026 8:10 PM - SEC Filing Form 3 Seaport Therapeutics, For: Apr 30 Filed by: Gladstein Lana April 30, 2026 8:08 PM - SEC Filing Form 3 Seaport Therapeutics, For: Apr 30 Filed by: Chen Michael Cunyuan April 30, 2026 8:06 PM - SEC Filing Form 3 Seaport Therapeutics, For: Apr 30 Filed by: HOMBACH ROBERT J. April 30, 2026 8:05 PM - SEC Filing Form 3 Seaport Therapeutics, For: Apr 30 Filed by: Loebel Antony April 30, 2026 8:05 PM - SEC Filing Seaport Therapeutics files 11.8M share IPO at $16-$18/sh April 27, 2026 6:10 AM - StreetInsider Seaport Therapeutics files for proposed IPO April 10, 2026 4:03 PM - StreetInsider Full Article List